Documentos relacionados

1. Subclassification of the molecular types of breast cancer based on the expression of immunohistochemical markers and evolution.
2. New Advances in Molecular Breast Cancer Pathology.
3. Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care system.
4. Tissue-resident FOLR2⁺ macrophages associate with CD8⁺ T cell infiltration in human breast cancer.
5. Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study.
6. Gene expression analysis of invasive breast carcinoma yields differential patterns in luminal subtypes of breast cancer.
7. Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer.
8. Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting.
9. Deciphering breast cancer: from biology to the clinic.
10. MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early-stage breast cancer patients.